Flortaucipir F-18

CHEBI:CHEBI_754264

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
marketing_start_date
20220701
package_marketing_start_date
20221025
labeler_name
Eli Lilly and Company
manufacturer_name
Eli Lilly and Company
active_ingredient_strength
100 mCi/mL
generic_name
Flortaucipir F-18
brand_name
TAUVID
brand_name_base
TAUVID
product_ndc
0002-1220
application_number
NDA212123
spl_id
f615e11a-4b7c-4d64-99d2-36bc282fa391
active_ingredient_name
FLORTAUCIPIR F-18
package_ndc
0002-1220-50
package_description
1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-50) / 50 mL in 1 VIAL, MULTI-DOSE
unii
T1JP1KYU9O
spl_set_id
b483abad-5230-462a-adfb-1a65160f01d0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class